Last viewed: TAK

Prices are updated after-hours

TAK Nyse 2020 - 06 - 03

Takeda Pharmaceutical Company Limited

TAK | News | $13.23 -1.12% 0.0% 920K

|

Health Technology

(0.0% 1d) (-8.1% 1m) (-21.3% 1y) (0.0% 2d) (-0.9% 3d) (0.2% 7d) (Infinity% volume)
Earnings Calendar:
Market Cap: $ 41,870,537,510
http://www.takeda.co.jp
Sec Filling | Patents | 47495 employees

Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. It operates through the following segments: Prescription Drug, Consumer Healthcare, and Other. The Prescription Drugs segment includes the manufacture and sale of pharmaceutical products. The Consumer Healthcare segment includes the manufacture and sale of OTC drugs and quasi-drugs. The Other segment includes manufacture and sale of reagents, clinical diagnostics, and chemical products. The company was founded by Takeda Chobei on June 12, 1781 and is headquartered in Osaka, Japan.

diagnostics qdenga dengue vaccine

add to watch list Paper trade email alert is off

Press-releases

Astellas' XTANDI™ (Enzalutamide) Granted European Commission Approval for Use in Additional Recurrent Early Prostate Cancer Treatment Setting
Published: 2024-04-23 (Crawled : 00:00) - prnewswire.com
ALPMY | News | $9.47 -0.21% -1.11% 400K

|

| -0.21% | O: -1.05% H: 0.85% C: 0.85%
TAK | News | $13.23 -1.12% 0.0% 920K

|

Health Technology

| -0.86% | O: -0.19% H: 0.08% C: -0.68%
granted approval cancer treatment for

Neurocrine Biosciences Reports Positive Phase 2 Data for NBI-1065845 in Adults with Major Depressive Disorder
Published: 2024-04-23 (Crawled : 13:30) - biospace.com/
TAK | News | $13.23 -1.12% 0.0% 920K

|

Health Technology

| -0.97% | O: -0.11% H: 0.0% C: 0.0%
NBIX | News 4 | $138.97 -0.8% -0.85% 930K

|

Health Technology

| 3.97% | O: 5.49% H: 2.84% C: -0.65%
nbi-1065 positive for

Takeda, Astellas and Sumitomo Mitsui Banking Announce Master Agreement to Establish Joint Venture Company for Incubation of Early Drug Discovery Programs
Published: 2024-04-22 (Crawled : 09:00) - prnewswire.com
SMFNF | News | $58.172 4.57% -1.2% 5

|

| 4.19% | O: -0.16% H: 3.14% C: 0.04%
ALPMY | News | $9.47 -0.21% -1.11% 400K

|

| -0.32% | O: 0.63% H: 0.0% C: -0.31%
TAK | News | $13.23 -1.12% 0.0% 920K

|

Health Technology

| 0.19% | O: 0.8% H: 0.75% C: 0.38%
drug company for agreement

Progressive Familial Intrahepatic Cholestasis Treatment Market Projected to Reach $156.14 million by 2030 - Exclusive Report by 360iResearch
Published: 2024-04-19 (Crawled : 02:00) - prnewswire.com
TAK | News | $13.23 -1.12% 0.0% 920K

|

Health Technology

| 0.61% | O: 0.42% H: 0.0% C: 0.0%
SNY | News | $46.61 -2.27% -2.21% 1.6M

|

Health Technology

| 4.25% | O: 0.82% H: 0.0% C: 0.0%
MIRM | $24.02 -1.64% -1.75% 320K

|

Health Technology

| 1.91% | O: -0.68% H: 2.52% C: 1.71%
report million reach treatment market

U.S. FDA Approves Subcutaneous Administration of Takeda’s ENTYVIO® (vedolizumab) for Maintenance Therapy in Moderately to Severely Active Crohn’s Disease
Published: 2024-04-18 (Crawled : 23:00) - biospace.com/
TAK | News | $13.23 -1.12% 0.0% 920K

|

Health Technology

| 0.61% | O: 0.0% H: 0.0% C: 0.0%
entyvio fda disease active for therapy

Neurvati Neurosciences Announces Appointment of Deborah Dunsire, MD, as Member and Chair of Company Board of Directors
Published: 2024-04-15 (Crawled : 12:00) - prnewswire.com
TAK | News | $13.23 -1.12% 0.0% 920K

|

Health Technology

| -1.78% | O: -1.19% H: 0.26% C: -0.98%
company

Takeda Announces Approval of ADZYNMA® Intravenous Injection 1500 (apadamtase alfa /cinaxadamtase alfa) in Japan for Patients with Congenital Thrombotic Thrombocytopenic Purpura (cTTP)
Published: 2024-03-26 (Crawled : 18:00) - biospace.com/
TAK | News | $13.23 -1.12% 0.0% 920K

|

Health Technology

| -6.5% | O: 1.84% H: 0.24% C: -0.14%
adzynma japan takeda approval injection

CENTOGENE Extends Strategic Partnership With Takeda to Continue Providing Access to Genetic Testing for Patients With Lysosomal Storage Disorders
Published: 2024-03-19 (Crawled : 11:00) - globenewswire.com
TAK | News | $13.23 -1.12% 0.0% 920K

|

Health Technology

| -9.13% | O: -0.07% H: 0.0% C: -0.96%
CNTG | $0.461 -3.96% -1.05% 20K

|

Commercial Services

| -34.29% | O: 1.43% H: 1.41% C: -1.41%
partnership genetic takeda disorders

Takeda Announces U.S. FDA Approval of Supplemental New Drug Application (sNDA) for ICLUSIG® (ponatinib) in Adult Patients with Newly Diagnosed Ph+ ALL
Published: 2024-03-19 (Crawled : 17:00) - biospace.com/
TAK | News | $13.23 -1.12% 0.0% 920K

|

Health Technology

| -9.13% | O: -0.07% H: 0.0% C: -0.96%
iclusig fda drug takeda approval application

Monoclonal Antibody (mABs) Therapeutics Market Worth $497.5 billion | MarketsandMarkets™
Published: 2024-03-15 (Crawled : 14:30) - prnewswire.com
TAK | News | $13.23 -1.12% 0.0% 920K

|

Health Technology

| -7.74% | O: 0.21% H: 0.97% C: 0.7%
NVS | News | $98.35 1.1% 0.69% 2.1M

|

Health Technology

| 0.22% | O: 0.05% H: 0.14% C: -0.93%
JNJ | News | $148.53 -0.69% 0.18% 7.5M

|

Health Technology

| -7.87% | O: -1.58% H: 0.0% C: 0.0%
LLY | News | $732.2 -1.81% -0.84% 1.7M

|

Health Technology

| -1.12% | O: -0.7% H: 0.73% C: -0.16%
ABBV | News | $167.8 -1.03% -0.02% 2.9M

|

Health Technology

| -6.94% | O: -0.07% H: 0.0% C: 0.0%
SNY | News | $46.61 -2.27% -2.21% 1.6M

|

Health Technology

| -2.03% | O: -0.02% H: 0.0% C: 0.0%
REGN | News | $906.54 -0.09% -0.08% 280K

|

Health Technology

| -5.47% | O: -0.27% H: 1.26% C: 0.84%
AMGN | News | $273.01 -0.19% -0.17% 1.5M

|

Health Technology

| 0.54% | O: 0.2% H: 1.14% C: -1.18%
antibody therapeutics market

See all

Last 15 days Sec forms

File Id

Form

Published Date

Transaction Date

Direction

Code

Amount Transacted

Owned Amount

Your Today's Watch List

Sign in to create a watchlist

Gainers vs Losers

62%

38%

Top 10 Gainers

CSSE 4 | $0.4253 179.25% 64.77% 210M

|

Consumer Services

BOF | $2.08 77.78% 41.21% 110M

|

ILAG | $0.54 12.27% 40.62% 3.7M

|

LICN | $0.999 78.39% 40.49% 15M

|

AMST | $3.4 70.0% 39.58% 70M

|

Technology Services

MTC | $3.6 60.71% 38.04% 9.1M

|

Technology Services

WIMI | $1.15 58.53% 36.92% 19M

|

Technology Services

AIH | $0.458 14.5% 30.92% 91K

|

Health Services

WHLM | $6.25 35.87% 28.46% 700K

|

Commercial Services

MULN | News | $3.77 38.1% 27.78% 13M

|

Last 48 Hours Insiders Buying

RKT P 347 | $12.55 -0.63% 1.12% 1.5M

|

| 22:30
NWFL | News | $24.21 0.42% 1.99% 9.9K

|

| 22:00
TGEN P 10000 | $0.68 -0.73% 39.71% 20K

|

| 20:01
MNSB P 310 | $15.89 -2.87% -3.02% 46K

|

| 15:30
RMCF | $3.55 0.28% 0.28% 7.1K

|

Consumer Non-Durables

| 20:10

12 months watchlist earnings calendar